Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.
Saved in:
| Title: | Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice. |
|---|---|
| Authors: | Weckmann K; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Deery MJ; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Howard JA; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Feret R; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Dethloff F; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Filiou MD; Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece., Labermaier C; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Maccarrone G; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Lilley KS; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Mueller M; Experimental Psychiatry, Department of Psychiatry and Psychotherapy and Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center, Mainz, Germany., Turck CW; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany. |
| Source: | Molecular neuropsychiatry [Mol Neuropsychiatry] 2019 Mar; Vol. 5 (1), pp. 42-51. Date of Electronic Publication: 2018 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101649121 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2296-9209 (Print) Linking ISSN: 22969179 NLM ISO Abbreviation: Mol Neuropsychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
